Attached files

file filename
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - CRC Health CORPdex321.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER - CRC Health CORPdex312.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER - CRC Health CORPdex322.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - CRC Health CORPdex311.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2009

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 333-135172

 

 

CRC HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   73-1650429

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

20400 Stevens Creek Boulevard,

Suite 600, Cupertino, California

  95014
(Address of principal executive offices)   (Zip code)

(877) 272-8668

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The total number of shares of the registrant’s common stock, par value of $0.001 per share, outstanding as of November 16, 2009 was 1,000.

 

 

 


Table of Contents

CRC HEALTH CORPORATION

INDEX

 

               Page No.
Part I.    Financial Information   
   Item 1.    Financial Statements (Unaudited)   
      Condensed Consolidated Balance Sheets as of September 30, 2009 and December 31, 2008    2
      Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2009 and 2008    3
      Condensed Consolidated Statement of Changes in Equity for the nine months ended September 30, 2009 and 2008    4
      Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2009 and 2008    5
      Notes to Condensed Consolidated Financial Statements    6
   Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    30
   Item 3.    Quantitative and Qualitative Disclosure About Market Risk    37
   Item 4.    Controls and Procedures    37
Part II.    Other Information   
   Item 1A.    Risk Factors    37
   Item 6.    Exhibits    37
Signature    38
Exhibit Index    39

Forward-Looking Statements

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I of this Quarterly Report, includes or may include “forward-looking statements.” All statements included herein, other than statements of historical fact, may constitute forward-looking statements. In some cases you can identify forward-looking statements by terminology such as “may,” “should” or “could.” Generally, the words “anticipates,” “believes,” “expects,” “intends,” “estimates,” “projects,” “plans” and similar expressions identify forward-looking statements. Although CRC Health Corporation (“CRC”) believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, among others, the following factors: changes in government reimbursement for CRC’s services; reductions in the availability of governmental and private financial aid for CRC’s youth treatment programs; CRC’s substantial indebtedness; changes in applicable regulations or a government investigation or assertion that CRC has violated applicable regulations; attempts by local residents to force the closure or relocation of CRC’s facilities; the potentially difficult, unsuccessful or costly integration of acquired operations and future acquisitions; the potentially difficult, unsuccessful or costly opening and operating of new treatment programs; the possibility that commercial payors for CRC’s services may undertake future cost containment initiatives; the limited number of national suppliers of methadone used in CRC’s outpatient treatment clinics; the failure to maintain established relationships or cultivate new relationships with patient referral sources; shortages in qualified healthcare workers; natural disasters such as hurricanes, earthquakes and floods; competition that limits CRC’s ability to grow; the potentially costly implementation of new information systems to comply with federal and state initiatives relating to patient privacy, security of medical information and electronic transactions; the potentially costly implementation of accounting and other management systems and resources in response to financial reporting and other requirements; the loss of key members of CRC’s management; claims asserted against CRC or lack of adequate available insurance; and certain restrictive covenants in CRC’s debt documents and other risks that are described herein, including but not limited to the items discussed in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 filed on March 27, 2009, and that are otherwise described from time to time in CRC’s Securities and Exchange Commission filings after this Quarterly Report. CRC assumes no obligation and does not intend to update these forward-looking statements.

 

1


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

SEPTEMBER 30, 2009 AND DECEMBER 31, 2008

(In thousands, except share amounts)

 

     September 30,
2009
    December 31,
2008
 

ASSETS

    

CURRENT ASSETS:

    

Cash and cash equivalents

   $ 6,454      $ 2,540   

Restricted cash

     875        —     

Accounts receivable, net of allowance for doubtful accounts of $5,410 in 2009 and $5,409 in 2008

     32,569        30,826   

Prepaid expenses

     5,613        7,703   

Other current assets

     1,263        1,618   

Deferred income taxes

     4,029        4,029   

Current assets of discontinued operations, facility exits

     16,170        14,125   
                

Total current assets

     66,973        60,841   

PROPERTY AND EQUIPMENT-Net

     124,276        129,728   

GOODWILL

     579,262        604,078   

INTANGIBLE ASSETS-Net

     344,306        354,463   

OTHER ASSETS

     19,426        20,065   
                

TOTAL ASSETS

   $ 1,134,243      $ 1,169,175   
                

LIABILITIES AND EQUITY

    

CURRENT LIABILITIES:

    

Accounts payable

   $ 4,642      $ 6,165   

Accrued liabilities

     30,519        29,061   

Income taxes payable

     6,102        1,201   

Current portion of long-term debt

     6,014        6,522   

Other current liabilities

     26,386        31,657   

Current liabilities of discontinued operations, facility exits

     1,428        703   
                

Total current liabilities

     75,091        75,309   

LONG-TERM DEBT-Less current portion

     629,042        646,630   

OTHER LONG-TERM LIABILITIES

     7,419        7,553   

LIABILITIES OF DISCONTINUED OPERATIONS, FACILITY EXITS

     1,738        1,909   

DEFERRED INCOME TAXES

     126,487        134,331   
                

Total liabilities

     839,777        865,732   
                

COMMITMENTS AND CONTINGENCIES (Note 11)

    

CRC HEALTH CORPORATION STOCKHOLDER’S EQUITY:

    

Common stock, $0.001 par value-1,000 shares authorized; 1,000 shares issued and outstanding at September 30, 2009 and December 31, 2008

     —          —     

Additional paid-in capital

     451,578        444,275   

Accumulated deficit

     (152,496 )     (134,764 )

Accumulated other comprehensive (loss)

     (4,861 )     (6,289 )
                

Total CRC Health Corporation stockholder’s equity

     294,221        303,222   
                

NONCONTROLLING INTEREST

     245        221   
                

Total equity

     294,466        303,443   
                

TOTAL LIABILITIES AND EQUITY

   $ 1,134,243      $ 1,169,175   
                

See notes to unaudited condensed consolidated financial statements.

 

2


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008

(In thousands)

 

    Three Months
Ended
September 30,
2009
    Three Months
Ended

September 30,
2008
    Nine Months
Ended

September 30,
2009
    Nine Months
Ended

September 30,
2008
 

NET REVENUE:

       

Net client service revenue

  $ 113,074      $ 121,325      $ 325,464      $ 349,908   

Other revenue

    1,650        2,146        5,417        6,125   
                               

Total net revenue

    114,724        123,471        330,881        356,033   
                               

OPERATING EXPENSES:

       

Salaries and benefits

    53,056        59,155        165,450        176,968   

Supplies, facilities and other operating costs

    32,438        35,647        95,126        103,525   

Provision for doubtful accounts

    1,558        1,663        4,614        4,909   

Depreciation and amortization

    5,678        5,690        17,005        16,778   

Asset impairment

    2,257        —          2,257        —     

Goodwill impairment

    24,919        142,238        24,919        142,238   
                               

Total operating expenses

    119,906        244,393        309,371        444,418   
                               

OPERATING (LOSS) INCOME

    (5,182 )     (120,922 )     21,510        (88,385 )

INTEREST EXPENSE, NET

    (11,519 )     (13,110 )     (35,337 )     (40,132 )

OTHER EXPENSE

    —          (1 )     (82 )     (34
                               

LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

    (16,701 )     (134,033 )     (13,909 )     (128,551 )

INCOME TAX EXPENSE (BENEFIT)

    993        (10,604     1,171        (8,357 )
                               

LOSS FROM CONTINUING OPERATIONS, NET OF TAX

    (17,694 )     (123,429     (15,080     (120,194 )

LOSS FROM DISCONTINUED OPERATIONS (net of tax benefit of ($429) and ($8,618) in the three months ended September 30, 2009 and 2008, and ($1,197) and ($9,342) in the nine months ended September 30, 2009 and 2008, respectively)

    (1,027 )     (16,204 )     (2,623 )     (17,564 )
                               

NET LOSS

    (18,721     (139,633 )     (17,703     (137,758 )

LESS: NET INCOME (LOSS) ATTRIBUTABLE TO THE NONCONTROLLING INTEREST

    148        301        29        (57 )
                               

NET LOSS ATTRIBUTABLE TO CRC HEALTH CORPORATION

  $ (18,869 )   $ (139,934   $ (17,732 )   $ (137,701 )
                               

AMOUNTS ATTRIBUTABLE TO CRC HEALTH CORPORATION:

       

LOSS FROM CONTINUING OPERATIONS, NET OF TAX

  $ (17,842 )   $ (123,718 )   $ (15,113 )   $ (120,116 )

DISCONTINUED OPERATIONS, NET OF TAX

    (1,027 )     (16,216 )     (2,619 )     (17,585 )
                               

NET LOSS ATTRIBUTABLE TO CRC HEALTH CORPORATION

  $ (18,869 )   $ (139,934 )   $ (17,732 )   $ (137,701 )
                               

See notes to unaudited condensed consolidated financial statements.

 

3


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2009

(In thousands, except share amounts)

 

                 CRC Health Corporation Stockholder’s Equity        
     Total     Comprehensive
Income
    Accumulated
(Deficit)
Retained
Earnings
    Accumulated
Other
Comprehensive
(Loss)
    Common
Stock
   Additional
Paid-in
Capital
    Noncontrolling
Interest
 

Beginning balance

   $ 303,443      $ —        $ (134,764   $ (6,289   $ —      $ 444,275      $ 221   

Noncontrolling interest buyout

     (89              (84     (5

Comprehensive loss:

               

Net loss for the nine months ended September 30, 2009

     (17,703     (17,703     (17,732            29   

Other comprehensive income, net of tax:

               

Unrealized gain on cash flow hedges

     1,428        1,428          1,428          
                           

Other comprehensive income

     1,428        1,428              
                           

Comprehensive loss

     (16,275   $ (16,275           
                           

Capital contributed by Parent, net

     7,387                 7,387     
                                                 

Ending balance

   $ 294,466        $ (152,496   $ (4,861   $ —      $ 451,578      $ 245   
                                                 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2008

(In thousands, except share amounts) *

 

                 CRC Health Corporation Stockholder’s Equity       
     Total     Comprehensive
Income
    Accumulated
(Deficit)
Retained
Earnings
    Accumulated
Other
Comprehensive
(Loss)
    Common
Stock
   Additional
Paid-in
Capital
   Noncontrolling
Interest
 

Beginning balance

   $ 446,123      $ —        $ 7,141      $ —        $ —      $ 438,608    $ 374   

Comprehensive loss:

                

Net loss for the nine months ended September 30, 2008

     (137,758     (137,758     (137,701             (57

Other comprehensive loss, net of tax:

                

Unrealized loss on cash flow hedges

     (1,000     (1,000       (1,000        
                            

Other comprehensive loss

     (1,000     (1,000            
                            

Comprehensive loss

     (138,758   $ (138,758            
                            

Capital contributed by Parent, net

     3,542                 3,542   
                                                

Ending balance

   $ 310,908        $ (130,559   $ (1,000   $ —      $ 442,150    $ 317   
                                                

 

* Note that figures in this table may not sum due to rounding.

See notes to unaudited condensed consolidated financial statements.

 

4


Table of Contents

CRC HEALTH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008

(In thousands)

 

     Nine Months Ended
September 30, 2009
    Nine Months Ended
September 30, 2008
 

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net loss

   $ (17,703   $ (137,758

Adjustments to reconcile net income(loss) to net cash provided by operating activities:

    

Depreciation and amortization

     17,148        17,343   

Amortization of debt discount and capitalized financing costs

     3,279        3,357   

Loss on interest rate swap agreement

     —          165   

Goodwill impairment

     24,919        142,238   

Asset impairment

     4,560        23,880   

Write-off of prior year paid acquisition costs

     62        —     

Loss on disposition of property and equipment

     880        21   

Gain on sale of discontinued operations

     (24     —     

Provision for doubtful accounts

     4,680        5,010   

Stock-based compensation

     4,164        3,847   

Deferred income taxes

     (5,897     (26,674

Changes in assets and liabilities:

    

Restricted cash

     (875     —     

Accounts receivable

     (6,438     (4,789

Prepaid expenses

     1,941        1,140   

Other current assets

     154        589   

Accounts payable

     (1,548     1,740   

Accrued liabilities

     1,475        (9,257

Income taxes payable

     4,215        7,101   

Other current liabilities

     (2,815     (6,992

Other long term assets

     (2,315     (39

Other long term liabilities

     (303     168   
                

Net cash provided by operating activities

     29,559        21,090   
                

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Additions of property and equipment

     (7,252     (18,587

Proceeds from sale of property and equipment

     141        101   

Proceeds from sale of discontinued operations

     475        —     

Acquisition of business, net of cash acquired

     —          (11,567

Acquisition adjustments

     (59     (10

Payments made under earnout arrangements

     (200     (2,947
                

Net cash used in investing activities

     (6,895     (33,010
                

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Capital distributed to Parent

     (221     (305

Capitalized financing costs

     (117     (187

Noncontrolling interest buyout

     (89     —     

Repayment of capital lease obligations

     (10     (17

Net (repayments)/borrowings under revolving line of credit

     (13,000     13,500   

Repayments of term loan and seller notes

     (5,313     (3,175
                

Net cash (used in) /provided by financing activities

     (18,750     9,816   
                

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     3,914        (2,104

CASH AND CASH EQUIVALENTS-Beginning of period

     2,540        5,118   
                

CASH AND CASH EQUIVALENTS-End of period

   $ 6,454      $ 3,014   
                

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING ACTIVITIES:

    

Payable for contingent consideration

   $ —        $ 641   
                

SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES:

    

Capital contributed by Parent

   $ 7,608      $ 3,847   
                

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

    

Cash paid for interest

   $ 37,211      $ 43,081   
                

Cash paid for income taxes, net of refunds

   $ 1,655      $ 1,430   
                

See notes to unaudited condensed consolidated financial statements.

 

5


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. BASIS OF PRESENTATION AND OVERVIEW

CRC Health Corporation (“the Company”) is a wholly owned subsidiary of CRC Health Group, Inc., referred to as “the Group” or “the Parent.” The Company is headquartered in Cupertino, California and through its wholly owned subsidiaries provides substance abuse treatment services and youth treatment services in the United States. The Company also provides treatment services for other addiction diseases and behavioral disorders such as eating disorders.

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X, without audit. Accordingly, they do not include all of the information required by accounting principles generally accepted in the United States of America for annual financial statements. The unaudited condensed consolidated balance sheet as of December 31, 2008 has been derived from our audited financial statements.

In the opinion of management, these unaudited condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the financial position of the Company, its results of operations, and its cash flows. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended December 31, 2008.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation - The Company’s condensed consolidated financial statements include the accounts of CRC Health Corporation and its consolidated subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates - Preparation of financial statements in accordance with generally accepted accounting principles in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

Business Segments - Effective January 1, 2009, the Company realigned its operations and internal organizational structure by combining its “youth division” with its “healthy living division”, formerly included as a component of “corporate/other.” Performance of the Company’s two reportable segments (recovery division and healthy living division) is evaluated based on profit or loss from operations (“segment profit”). Management uses segment profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Intersegment sales and transfers are insignificant.

 

6


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Recently Adopted Accounting Guidance - During the third quarter of 2009, the Company adopted the new Accounting Standards Codification (ASC) as issued by the Financial Accounting Standards Board (FASB). The ASC has become the source of authoritative US GAAP recognized by the FASB to be applied by nongovernmental entities. The ASC is not intended to change or alter existing GAAP. The adoption of the ASC did not have a material impact on the Company’s consolidated financial statements.

In May 2009, the FASB issued new accounting and disclosure guidance for recognized and non-recognized subsequent events that occur after the balance sheet date but before financial statements are issued. The new guidance also requires disclosure of the date through which an entity has evaluated subsequent events and the basis for that date. The new accounting guidance was effective for the Company beginning with three and six months ended June 30, 2009, and is being applied prospectively. This change in accounting policy had no impact on the condensed consolidated financial statements.

In April 2009, the FASB issued new disclosure guidance which requires enhanced interim period disclosures about the fair value of financial instruments. The new guidance requires disclosure of the methods and significant assumptions used to estimate fair value of financial instruments on an interim basis as well as changes of the methods and significant assumptions from prior periods. The Company applied the new accounting pronouncements beginning with three and six months ended June 30, 2009, and is being applied prospectively. The adoption did not have a material impact on the consolidated financial statements.

In March 2008, the FASB amended existing disclosure requirements related to derivative and hedging activities, which became effective for the Company on January 1, 2009, and is being applied prospectively. As a result of the amended disclosure requirements, the Company is required to provide expanded qualitative and quantitative disclosures about derivatives and hedging activities in each interim and annual period. The adoption of the new disclosure requirements had no material impact on the consolidated financial statements.

In December 2007, the FASB amended its guidance on accounting for business combinations. The new accounting guidance resulted in a change in the Company’s accounting policy effective January 1, 2009, and is being applied prospectively to all business combinations subsequent to the effective date. Among other things, the new guidance amends the principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree and the goodwill acquired. It also establishes new disclosure requirements to enable the evaluation of the nature and financial effects of the business combination. The adoption of this new accounting policy did not have a significant impact on the consolidated financial statements, and the impact it will have on the consolidated financial statements in future periods will depend on the nature and size of business combinations completed subsequent to the date of adoption.

In December 2007, the FASB issued new accounting and disclosure guidance related to noncontrolling interests in subsidiaries (previously referred to as minority interests), which resulted in a change in accounting policy effective January 1, 2009. Among other things, the new guidance requires that a noncontrolling interest in a subsidiary be accounted for as a component of equity separate from the parent’s equity, rather than as a liability. The new guidance is being applied prospectively, except for the presentation and disclosure requirements, which have been applied retrospectively. The adoption of this new accounting policy did not have a significant impact on the consolidated financial statements.

Recent Accounting Guidance Not Yet Adopted - In August 2009, the FASB issued a new accounting standard which provides additional guidance on the measurement of liabilities at fair value. Specifically, when a quoted price in an active market for the identical liability is not available, the new standard requires that the fair value of a liability be measured using one or more of the valuation methods permitted by the guidance.

 

7


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

3. BALANCE SHEET COMPONENTS

Balance sheet components at September 30, 2009 and December 31, 2008 consist of the following (in thousands):

 

     September 30,
2009
    December 31,
2008
 

Accounts receivable

   $ 37,979      $ 36,235   

Less allowance for doubtful accounts

     (5,410     (5,409
                

Accounts receivable-net

   $ 32,569      $ 30,826   
                

Other assets:

    

Capitalized financing costs-net

   $ 15,725      $ 18,688   

Deposits

     928        912   

Note receivable

     2,773        465   
                

Total other assets

   $ 19,426      $ 20,065   
                

Accrued liabilities:

    

Accrued payroll and related expenses

   $ 13,235      $ 7,864   

Accrued vacation

     5,077        5,613   

Accrued interest

     3,364        8,289   

Accrued expenses

     8,843        7,295   
                

Total accrued liabilities

   $ 30,519      $ 29,061   
                

Other current liabilities:

    

Deferred revenue

   $ 10,869      $ 10,249   

Client deposits

     4,976        5,114   

Insurance premium financing

     —          2,226   

Interest rate swap liability

     9,698        12,110   

Other liabilities

     843        1,958   
                

Total other current liabilities

   $ 26,386      $ 31,657   
                

 

8


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

4. PROPERTY AND EQUIPMENT

Property and equipment at September 30, 2009 and December 31, 2008 consist of the following (in thousands):

 

     September 30,
2009
    December 31,
2008
 

Land

   $ 21,373      $ 21,373   

Building and improvements

     73,973        65,733   

Leasehold improvements

     22,813        22,147   

Furniture and fixtures

     12,330        11,556   

Computer equipment

     9,615        9,474   

Computer software

     11,269        9,495   

Motor vehicles

     5,842        5,568   

Field equipment

     2,775        2,901   

Construction in progress

     4,176        12,013   
                
     164,166        160,260   

Less accumulated depreciation

     (39,890     (30,532
                

Property and equipment-net

   $ 124,276      $ 129,728   
                

Depreciation expense was $3.8 million and $3.6 million for the three months ended September 30, 2009 and 2008, respectively, and $11.5 million and $10.5 million for the nine months ended September 30, 2009 and 2008, respectively.

The Company tests its long-lived assets for impairment whenever events and changes in circumstances indicate that the carrying value of certain of its assets may not be recoverable. If the undiscounted future cash flows from the assets tested are less than the carrying value, a loss equal to the difference between the carrying value and the fair market value of the asset is recorded. Fair market value is determined using discounted cash flow methods. The Company’s analysis of its undiscounted cash flows requires judgment with respect to many factors, including future cash flows, success at executing its business strategy, and future revenue and expense growth rates. It is possible that the Company’s estimates of undiscounted cash flows may change in the future resulting in the need to reassess the carrying value of its long-lived assets for impairment.

At September 30, 2009, the Company tested the fixed assets within its healthy living segment for possible impairment as a result of triggering events related to the negative economic environment and continuation of the depressed consumer credit markets. For the three months and nine months ended September 30, 2009, the Company recognized a non-cash impairment charge of $0.2 million related to impairment of property and equipment which is recorded under asset impairment on the condensed consolidated statement of operations.

5. GOODWILL AND INTANGIBLE ASSETS

Changes to goodwill by reportable segments for the nine months ended September 30, 2009 are as follows (in thousands):

 

     Recovery     Healthy
Living
    Total  

Goodwill December 31, 2008

   $ 501,531      $ 102,547      $ 604,078   

Goodwill impairment

     —          (24,919     (24,919

Goodwill adjustments

     (97     —          (97

Goodwill related to earn-outs

     200        —          200   
                        

Goodwill September 30, 2009

   $ 501,634      $ 77,628      $ 579,262   
                        

Goodwill impairment

During the third quarter of 2009, the Company reduced its estimate of expected future cash flows for the healthy living division based upon current economic conditions including the lack of availability of student loans, credit for our clients, and other factors. Accordingly, the Company tested its healthy living division in advance of the annual goodwill impairment test date as there was a significant adverse change in business climate and recognized a non-cash impairment charge of $24.9 million. Goodwill impairment charges, recognized by the Company during the three months ended September 30, 2009, are estimated amounts which are subject to revision during the fourth quarter of 2009 as more information becomes available.

Goodwill adjustments

During the nine months ended September 30, 2009, the Company consummated the sale of three facilities in its recovery division which were classified as held for sale at December 31, 2008. The Company allocated approximately $0.1 million of goodwill to the facilities upon disposal.

 

9


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Goodwill related to earnouts

Certain acquisition agreements related to the purchase of a facility within the recovery division contain contingent earnout provisions that provide for additional consideration to be paid to the sellers under certain conditions. During the three months and nine months ended September 30, 2009, the recovery division recorded $0.2 million in additional goodwill related to an earnout agreement with the sellers of the facility.

Intangible Assets

Total intangible assets at September 30, 2009 and December 31, 2008 consist of the following (in thousands):

 

     September 30, 2009    December 31, 2008
   Useful
Life
   Gross
Carrying
Amount
   Accumulated
Amortization
    Net
Carrying
Amount
   Useful
Life
   Gross
Carrying
Amount
   Accumulated
Amortization
    Net
Carrying
Amount

Intangible assets subject to amortization:

                     

Referral network

   20 years    $ 33,306    $ (4,779   $ 28,527    20 years    $ 35,914    $ (3,823   $ 32,091

Accreditations

   20 years      15,329      (2,213     13,116    20 years      16,118      (1,722     14,396

Curriculum

   20 years      7,955      (1,144     6,811    20 years      8,743      (929     7,814

Government including

                     

Medicaid contracts

   15 years      34,971      (8,549     26,422    15 years      34,979      (6,806     28,173

Managed care contracts

   10 years      14,400      (5,280     9,120    10 years      14,400      (4,200     10,200

Managed care contracts

   5 years      100      (40     60    5 years      100      (25     75

Core developed technology

   5 years      2,704      (1,987     717    5 years      2,704      (1,582     1,122

Covenants not to compete

   3 years      —        —          —      3 years      152      (152     —  
                                                 

Total intangible assets subject to amortization:

      $ 108,765    $ (23,992   $ 84,773       $ 113,110    $ (19,239   $ 93,871
                                                 

Intangible assets not subject to amortization:

                     

Trademarks and trade names

           $ 176,020            $ 176,587

Certificates of need

             44,600              44,600

Regulatory licenses

             38,913              39,405
                             

Total intangible assets not subject to amortization

             259,533              260,592
                             

Total intangible assets

           $ 344,306            $ 354,463
                             

Intangible assets subject to amortization

During the three and nine months ended September 30, 2009, the Company continued its restructuring activities initiated in 2008 (the “FY08 Plan”). For the three months and nine months ended September 30 2009, the Company recognized a non-cash impairment charge of $0.6 million and $1.5 million related to finite-lived intangible assets. These impairment charges are based on the Company’s decision to close two of its healthy living program facilities and reduce the carrying value of certain of its finite-lived intangible assets to their estimated fair value. Impairment charges related to facility closures are included in the condensed consolidated statements of operations under results from discontinued operations and are reflected in the healthy living reporting segment. See Note 15.

At September 30, 2009, the Company tested its finite lived intangible assets for possible impairment due to negative economic conditions including the lack of availability of student loans, credit for our clients, and other factors which indicated that the carrying value of certain of its assets may not be recoverable. The Company records impairments when the undiscounted future cash flow from an asset tested is less than the carrying value of that asset, losses are measured based on the difference between the carrying value and the fair market value of the asset. Fair value is determined based on a discounted cash flow model. For the three months and nine months ended September 30, 2009, the Company determined that certain finite-lived intangible assets within its healthy living segment were impaired. Accordingly, the Company recognized a non-cash charge of $2.1 million which is included in the condensed consolidated statements of operations under asset impairment. These impairment charges reduce the carrying value of certain of its finite-lived intangible assets to their estimated fair value.

 

10


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Total amortization expense of intangible assets subject to amortization was $1.8 million and $2.1 million for the three months ended September 30, 2009 and 2008, respectively, and $5.5 million and $6.3 million for the nine months ended September 30, 2009 and 2008, respectively.

Estimated future amortization expense related to the amortizable intangible assets at September 30, 2009 is as follows (in thousands):

 

Fiscal Year

    

2009 (remaining three months)

   $ 1,793

2010

     7,175

2011

     6,676

2012

     6,629

2013

     6,614

Thereafter

     55,886
      

Total

   $ 84,773
      

Intangible assets not subject to amortization

During the three months and nine months ended September 30, 2009, in conjunction with the Company’s decision to close two facilities within its healthy living division as part of the Company’s FY08 plan, the Company determined that certain indefinite-lived intangible assets were impaired. Accordingly, the Company recognized a non-cash impairment charge of approximately of $0.3 million and $0.8 million during the three months and nine months ended September 30, 2009, respectively. Charges related to impairment of indefinite-lived intangible assets are included in the Company’s condensed consolidated statement of operations under results of discontinued operations.

6. INCOME TAXES

The Company determines its income tax expense for interim periods by applying the use of the full year’s estimated effective tax rate in financial statements for interim periods.

For the three and nine months ended September 30, 2009, the Company’s tax expense on continuing operations was $1.0 million and $1.2 million respectively, representing respective effective tax rates of (5.9)% and (8.4)%. The overall effective tax rate on continuing operations differs from the U.S. federal statutory rate of 35% due to certain discrete items and state income taxes. The effective tax rate for the nine months ended September 30, 2009 for continuing operations is 44.3%.

For the nine months ended September 30, 2009, the discrete items affecting the Company’s tax rate are as follows:

 

   

A change in California law that resulted in a $1.1 million tax benefit due to a decrease in the tax used to calculate deferred taxes. As a result of change in this law, the Company expects that as its deferred tax liabilities reverse in years after 2010, it will be subject to a lower state effective tax rate due to the projected reduction in the California apportionment percentage. The Company will continue to assess the value of reversal items on its California deferred tax liability in future periods.

 

   

A goodwill impairment charge of $24.9 million. Of the $24.9 million impairment, $19.6 million was non-deductible for tax purposes and affected the Company’s effective tax rate.

 

   

Upon completion of the filing of the 2008 tax returns, the Company recorded a provision-to-return adjustment. The adjustment resulted in a total increased income tax expense of $0.8 million.

 

   

For the nine months ended September 30, 2009, the income tax benefit resulting from tax restructuring changes made to date resulted in an income tax benefit of $1.3 million.

        The Company files its income tax returns in various jurisdictions, including United States federal and state filings, Canada and United Kingdom filings. The Company is currently under examination by the Internal Revenue Service for the 2006 tax year, as well as by various state jurisdictions. There are different interpretations of tax laws and regulations and, as a result, significant disputes may arise with these tax authorities involving issues of the timing and amount of deductions and allocations of income among various tax jurisdictions. While the Company believes its positions comply with applicable laws, it periodically evaluates its exposures associated with its tax filing positions.

 

11


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

7. LONG-TERM DEBT

Long-term debt at September 30, 2009 and December 31, 2008 consists of the following (in thousands):

 

     September 30,
2009
    December 31,
2008
 

Term loan

   $ 406,697      $ 409,841   

Revolving line of credit

     48,500        61,500   

Senior subordinated notes, net of discount of $1,672 in 2009 and $1,870 in 2008

     175,624        175,426   

Seller notes

     4,103        6,216   

Lessor financing, leasehold improvements

     130        157   

Capital lease obligations

     2        12   
                

Total debt

     635,056        653,152   

Less current portion

     (6,014 )     (6,522 )
                

Long-term debt-less current portion

   $ 629,042      $ 646,630   
                

Interest expense on total debt was $11.6 million for the three months ended September 30, 2009 inclusive of $0.1 million of capitalized interest, and $13.1 million for the three months ended September 30, 2008 inclusive of $0.2 million of capitalized interest. Interest expense on total debt was $35.4 million for the nine months ended September 30, 2009 inclusive of $0.2 million of capitalized interest, and $40.2 million for the nine months ended September 30, 2008 inclusive of $0.6 million of capitalized interest.

8. DERIVATIVES

The Company uses interest rate swaps to manage risk related to fluctuations in interest rates and does not engage in speculation or trading activities with its interest rate swaps.

The effective portion of changes in the fair value of interest rate swaps designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During the three and nine months ending September 30, 2009, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings.

As of September 30, 2009, the Company had two outstanding interest rate derivatives with a combined $237.5 million notional amounts that were designated as cash flow hedges of interest rate risk. One of the derivatives (the “2006 Swap”) with a maturity date of March 31, 2011, converts $37.5 million of its floating-rate debt to fixed-rate debt at 4.99%. For the second derivative (the “2008 Swap”) with a maturity date of June 30, 2011, the Company receives an interest rate equal to 3-month LIBOR and in exchange pays a fixed rate of 3.875% on the $200.0 million notional amount.

Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $6.3 million of the effective portion of its derivatives will be reclassified as an increase to interest expense.

 

12


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

The table below presents the fair value of the Company’s derivative financial instruments at September 30, 2009 and December 31, 2008 (in thousands):

 

     Liability Derivatives
   Balance Sheet
Location
   Fair Value
        September 30,
2009
   December 31,
2008

Derivatives designated as hedging instruments

        

Interest Rate Swaps

   Other current liabilities    $ 9,698    $ 12,110
                

Total derivatives designated as hedging instruments

      $ 9,698    $ 12,110
                

The table below presents the before-tax effect of the Company’s derivative financial instruments for the three months ending September 30, 2009 and 2008 (in thousands):

 

Cash

Flow Hedging

Relationships

   Amount of
Gain or (Loss)
Recognized in

OCI on
Derivative
(Effective
Portion)
    Location of Gain
or (Loss)
Reclassified from
Accumulated OCI

into Income
(Effective Portion)
   Amount of
Gain or (Loss)
Reclassified

from
Accumulated
OCI into
Income
(Effective
Portion)
    Location of Gain or
(Loss) Recognized in
Income on Derivative
(Ineffective Portion

and Amount
Excluded from
Effectiveness Testing)
   Amount of Gain
or (Loss)
Recognized in
Income on
Derivative
(Ineffective
Portion and
Amount Excluded
from Effectiveness
Testing)
 
     Q3’09     Q3’08          Q3’09     Q3’08          Q3’09     Q3’08  
Interest Rate Swaps    $ (2,140   $ (1,803 )   Interest expense, net    $ (1,997   $ (678 )   Interest expense, net    $ (170   $ (1

The table below presents the before-tax effect of the Company’s derivative financial instruments for the nine months ending September 30, 2009 and 2008 (in thousands):

 

Cash

Flow Hedging

Relationships

   Amount of
Gain or (Loss)
Recognized in

OCI on
Derivative
(Effective
Portion)
    Location of Gain
or (Loss)
Reclassified from
Accumulated OCI into
Income
(Effective Portion)
   Amount of
Gain or (Loss)
Reclassified

from
Accumulated
OCI into
Income
(Effective
Portion)
    Location of Gain or
(Loss) Recognized in
Income on Derivative
(Ineffective Portion
and Amount
Excluded from
Effectiveness Testing)
   Amount of Gain
or (Loss)
Recognized in
Income on
Derivative
(Ineffective
Portion and
Amount Excluded
from Effectiveness
Testing)
 
     2009     2008          2009     2008          2009     2008  

Interest Rate Swaps

   $ (2,726   $ (1,803   Interest expense, net    $ (5,138   $ (678   Interest expense, net    $ (591   $ (1

Credit-risk-related Contingent Features

The Company has agreements with one of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations.

As of September 30, 2009, the liability due to counterparties to the derivative agreements is $11.3 million, which includes accrued interest but excludes any adjustment for nonperformance risk (“credit valuation adjustments”). As of September 30, 2009, the

 

13


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Company has not posted any collateral related to these agreements. If the Company had breached any of these provisions at September 30, 2009, it may be required to settle its obligations under the agreements at their termination value of $11.3 million. At September 30, 2009, the Company was in compliance with all agreements related to its debt and derivatives.

9. FAIR VALUE MEASUREMENTS

The Company accounts for certain assets and liabilities at fair value. As defined in the authoritative guidance on fair value measurements, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. An asset or liability’s level is based on the lowest level of input that is significant to the fair value measurement. The statement requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

 

Level 1:   Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2:   Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable;
Level 3:   Unobservable inputs in which little or no market activity exists, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company values its interest rate swaps using terminal values which are derived using proprietary models based upon well recognized financial principles and reasonable estimates about relevant future market conditions at September 30, 2009 and December 31, 2008. These instruments are allocated to Level 2 on the fair value hierarchy because the critical inputs into these models, including the relevant yield curves and the known contractual terms of the instrument, are readily available. See Note 8.

Non-Financial Assets and Liabilities

The Company measures, on a non-recurring basis, its long-lived assets and indefinite-lived intangible assets at fair value when performing impairment assessments under the relevant accounting guidance. The Company also performs fair value measurements when conducting the step one and step two of the goodwill impairment analysis. Nonfinancial liabilities for exit or disposal activities are measured at fair value.

The following table presents the non-financial assets that were measured and recorded at fair value on a nonrecurring basis as of September 30, 2009 (in thousands):

 

     Nine Months Ended September 30, 2009    Level Used to Determine New Cost Basis
     Impairment
Charge
   New Cost
Basis
   Level 1    Level 2    Level 3

Referral network

   $ 2,234    —      $ —      $ —      $ —  

Accreditation

     676    —        —        —        —  

Curriculum

     681    —        —        —        —  

Regulatory licenses

     493    —        —        —        —  

Trademarks and trade names

     263    —        —        —        —  

Goodwill – healthy living reporting unit

     24,919    77,628      —        —        77,628
                                

Total

   $ 29,266    77,628    $ —      $ —      $ 77,628
                                

The Company recognized an impairment charge of approximately $4.3 million related to certain intangible assets for the nine months ended September 30, 2009. The carrying value of the assets prior to the impairment was approximately $4.3 million. As of September 30, 2009, the estimated fair value of the assets was zero and was determined based on level 3 inputs.

 

14


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Fair Value of Financial Instruments

The Company’s financial instruments include cash, restricted cash, accounts receivable, accounts payable, interest rate derivatives, and borrowings.

The Company records long-term debt at carrying value in the condensed consolidated balance sheet. Based upon the borrowing rates currently available to the Company for loans with similar terms and the anticipated payment of its term loans per the amended and restated credit agreement the carrying value of the term loans approximates fair value. See Note 7.

Loan program notes are measured at fair value using Level 2 inputs based on the 90-day Libor rate plus a margin based on consumer credit scores. The Company’s senior subordinated notes are measured at fair value using Level 2 inputs based on bond-yield data from market trading activity as well as U.S Treasury rates with similar maturities as the senior subordinated notes.

The fair value of the Company’s financial instruments, with the exceptions as noted below, approximate the carrying value due to their short maturities.

 

     September 30, 2009
   (in Thousands)
   Carrying
Amount
   Fair Value

Assets

     

Loan program notes

     2,394      2,547
             

Total Assets

   $ 2,394    $ 2,547
             

Liabilities

     

Senior subordinated notes

     175,624      130,474
             

Total Liabilities

   $ 175,624    $ 130,474
             

 

15


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

10. COMPREHENSIVE INCOME (LOSS)

Comprehensive income (loss) includes other gains and losses affecting equity that are excluded from net income. The components of comprehensive income (loss) consist of changes in the fair value of derivative financial instruments.

Comprehensive income (loss) for the three and nine months ended September 30, 2009 and 2008 was as follows (in thousands):

 

    Three Months
Ended

September 30,
2009
    Three Months
Ended

September 30,
2008
    Nine Months
Ended

September 30,
2009
    Nine Months
Ended

September 30,
2008
 

Net loss

  $ (18,721 )   $ (139,633 )   $ (17,703 )   $ (137,758 )

Other comprehensive income (loss):

       

Net change in unrealized (loss)/gain on cash flow hedges (net of tax)

    (112     (647     1,428        (1,000

Other comprehensive income (loss) attributable to noncontrolling interest

    —          —          —          —     
                               

Total comprehensive loss

  $ (18,833 )   $ (140,280 )   $ (16,275 )   $ (138,758 )
                               

Comprehensive income (loss) attributable to noncontrolling interest

  $ 148      $ 301      $ 29      $ (57
                               

Comprehensive loss attributable to CRC Health Corporation

  $ (18,981 )   $ (140,581   $ (16,304 )   $ (138,701 )
                               

11. COMMITMENTS AND CONTINGENCIES

Indemnifications - The Company provides for indemnification of directors, officers and other persons in accordance with limited liability agreements, certificates of incorporation, bylaws, articles of association or similar organizational documents, as the case may be. The Company maintains directors’ and officers’ insurance which should enable the Company to recover a portion of any future amounts paid should they occur.

In addition to the above, from time to time the Company provides standard representations and warranties to counterparties in contracts in connection with business dispositions and acquisitions and also provides indemnities that protect the counterparties to these contracts in the event they suffer damages as a result of a breach of such representations and warranties or in certain other circumstances relating to such sales or acquisitions.

While the Company’s future obligations under certain agreements may contain limitations on liability for indemnification, other agreements do not contain such limitations and under such agreements it is not possible to predict the maximum potential amount of future payments due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved.

Litigation - The Company is involved in litigation and regulatory investigations arising in the course of business. After consultation with legal counsel, management estimates that these matters will be resolved without material adverse effect on the Company’s future financial position or results from operations and cash flows.

Loan Program Purchase Commitments - Effective April 1, 2009, the Company created a private loan program (“the Loan Program”) pursuant to which students and/or clients who meet predetermined credit standards can obtain third-party financing to pay a portion of the cost of participating in certain of our programs. During the three and nine months ended September 30, 2009, we were party to an agreement with an unrelated third party (“Lender”) to purchase certain amounts of Loan Program notes on a recurring basis. In accordance with the Agreement, the Company can terminate the Loan Program at any time upon a 120 day advance notice of termination to the Lender.

The Company has an executory commitment to purchase, from the Lender, the notes that meet the predetermined Loan Program criteria not to exceed total loan pool investment amounts authorized by the Company’s board of directors. As of September 30, 2009, the Board of Directors has approved a loan pool of up to $20.0 million for 2009 and 2010 combined. At September 30, 2009, the Company had purchased approximately $2.4 million in Loan Program notes with a weighted average interest rate of 7.8% and a maximum remaining amortization period of 20 years. Loan program notes are recorded under other assets on the Company’s condensed consolidated balance sheets. The Company has the intent and ability to hold these loan notes to maturity.

 

16


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

12. STOCK-BASED COMPENSATION

Stock based equity awards are made by the Group to certain employees of the Company. The Company incurs stock-based compensation expense related to the equity awards made by the Group to employees and consultants of the Company. For the three and nine months ended September 30, 2009 the Company recognized stock-based compensation expense of $1.4 million and $4.2 million in 2009 and $1.5 million and $3.8 million in 2008 respectively. Stock-based compensation expense is recorded within salaries and benefits on the condensed consolidated statements of operations. The total income tax benefit recognized in the condensed consolidated statement of operations for stock option-based compensation expense for the three months and nine months ended September 30, was $0.5 million and $1.6 million for 2009 and $0.5 million and $1.5 million for 2008.

During the nine months ended September 30, 2009, the Group granted 20,440 units, which represent 183,960 share options to purchase Class A common stock of the Group and 20,440 share options to purchase Class L common stock of the Group. The weighted average grant date fair value for share options granted during the nine months ended September 30, 2009 was $2.20 per share.

Activity under the Group’s Plans for the nine months ended September 30, 2009 is summarized below:

 

     Option Shares     Weighted-
Average
Exercise
Price
Per Share
   Weighted-
Average
Remaining
Contractual Term
(In Years)

Balance at December 31, 2008

   7,310,873      $ 7.97    7.44

Granted

   204,401        9.00    9.45

Exercised

   —          —     

Forfeited/cancelled/expired

   (340,100 )     8.86   
               

Outstanding-September 30, 2009

   7,175,174      $ 7.95    6.75
               

Exercisable-September 30, 2009

   3,321,386      $ 6.25    6.52
               

Exercisable and expected to be exercisable

   6,816,415      $ 7.95    6.75
               

13. CONDENSED CONSOLIDATING FINANCIAL INFORMATION

As of September 30, 2009, the Company had $177.3 million aggregate principal amount of the 10.75% Senior Subordinated Notes due 2016 (“the Notes”) outstanding. The Notes are fully and unconditionally guaranteed, jointly and severally on an unsecured senior subordinated basis, by the Company’s wholly owned subsidiaries.

The following supplemental tables present condensed consolidating balance sheets for the Company and its subsidiary guarantors as of September 30, 2009 and December 31, 2008, the condensed consolidating statements of operations for the three months and nine months ended September 30, 2009 and 2008, and the condensed consolidating statements of cash flows for the nine months ended September 30, 2009 and 2008.

 

17


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Balance Sheet as of September 30, 2009

(In thousands) (Unaudited)

 

     CRC Health
Corporation
   Subsidiary
Guarantors
   Subsidiary
Non-Guarantors
   Eliminations     Consolidated

ASSETS

             

CURRENT ASSETS:

             

Cash and cash equivalents

   $ —      $ 5,579    $ 875    $ —        $ 6,454

Restricted cash

     875      —        —        —          875

Accounts receivable-net of allowance

     —        32,143      426      —          32,569

Prepaid expenses

     2,066      3,359      188      —          5,613

Other current assets

     54      1,169      40      —          1,263

Deferred income taxes

     4,029      —        —        —          4,029

Current assets of discontinued operations, facility exits

     768      15,402      —        —          16,170
                                   

Total current assets

     7,792      57,652      1,529      —          66,973

PROPERTY AND EQUIPMENT-Net

     7,860      114,179      2,237      —          124,276

GOODWILL

     —        567,464      11,798      —          579,262

INTANGIBLE ASSETS-Net

     —        344,306      —        —          344,306

OTHER ASSETS

     18,217      1,191      18      —          19,426

INVESTMENT IN SUBSIDIARIES

     1,048,714      —        —        (1,048,714     —  
                                   

TOTAL ASSETS

   $ 1,082,583    $ 1,084,792    $ 15,582    $ (1,048,714   $ 1,134,243
                                   

LIABILITIES AND EQUITY

             

CURRENT LIABILITIES:

             

Accounts payable

   $ 2,741    $ 1,742    $ 159    $ —        $ 4,642

Accrued liabilities

     12,074      17,559      886      —          30,519

Income tax payable

     6,102      —        —        —          6,102

Current portion of long-term debt

     4,193      1,821      —        —          6,014

Other current liabilities

     10,050      15,369      967      —          26,386

Current liabilities of discontinued operations, facility exits

     —        1,428      —        —          1,428
                                   

Total current liabilities

     35,160      37,919      2,012      —          75,091

LONG-TERM DEBT-Less current portion

     626,629      2,413      —        —          629,042

OTHER LONG-TERM LIABILITIES

     86      7,301      32      —          7,419

LIABILITIES OF DISCONTINUED OPERATIONS, FACILITY EXITS

     —        1,738      —        —          1,738

DEFERRED INCOME TAXES

     126,487      —        —        —          126,487
                                   

Total liabilities

     788,362      49,371      2,044      —          839,777

CRC HEALTH CORPORATION STOCKHOLDER’S EQUITY

     294,221      1,035,421      13,293      (1,048,714     294,221

NONCONTROLLING INTEREST

     —        —        245      —          245
                                   

Total equity

     294,221      1,035,421      13,538      (1,048,714     294,466
                                   

TOTAL LIABILITIES AND EQUITY

   $ 1,082,583    $ 1,084,792    $ 15,582    $ (1,048,714   $ 1,134,243
                                   

 

18


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Balance Sheet as of December 31, 2008

(In thousands) (Unaudited)

 

     CRC Health
Corporation
   Subsidiary
Guarantors
   Subsidiary
Non-Guarantors
   Eliminations     Consolidated

ASSETS

             

CURRENT ASSETS:

             

Cash and cash equivalents

   $ —      $ 2,180    $ 360    $ —        $ 2,540

Accounts receivable-net of allowance for doubtful accounts

     2      30,390      434      —          30,826

Prepaid expenses

     4,420      3,204      79      —          7,703

Other current assets

     31      1,543      44      —          1,618

Deferred income taxes

     4,029      —        —        —          4,029

Current assets of discontinued operations, facility exits

     —        14,125      —        —          14,125
                                   

Total current assets

     8,482      51,442      917      —          60,841

PROPERTY AND EQUIPMENT-Net

     8,712      118,358      2,658      —          129,728

GOODWILL

     —        592,280      11,798      —          604,078

INTANGIBLE ASSETS-Net

     —        354,463      —        —          354,463

OTHER ASSETS

     18,778      1,266      21      —          20,065

INVESTMENT IN SUBSIDIARIES

     1,082,757      —        —        (1,082,757     —  
                                   

TOTAL ASSETS

   $ 1,118,729    $ 1,117,809    $ 15,394    $ (1,082,757   $ 1,169,175
                                   

LIABILITIES AND EQUITY

             

CURRENT LIABILITIES:

             

Accounts payable

   $ 3,636    $ 2,424    $ 105    $ —        $ 6,165

Accrued liabilities

     14,819      13,514      728      —          29,061

Income taxes payable

     1,201      —        —        —          1,201

Current portion of long-term debt

     4,193      2,329      —        —          6,522

Other current liabilities

     14,603      16,354      700      —          31,657

Current liabilities of discontinued operations, facility exits

     —        703      —        —          703
                                   

Total current liabilities

     38,452      35,324      1,533      —          75,309

LONG-TERM DEBT-Less current portion

     642,575      4,055      —        —          646,630

OTHER LONG-TERM LIABILITIES

     149      7,378      26      —          7,553

LIABILITIES OF DISCONTINUED OPERATIONS, FACILITY EXITS

     —        1,909      —        —          1,909

DEFERRED INCOME TAXES

     134,331      —        —        —          134,331
                                   

Total liabilities

     815,507      48,666      1,559      —          865,732

CRC HEALTH CORPORATION STOCKHOLDER’S EQUITY

     303,222      1,069,143      13,614      (1,082,757     303,222

NONCONTROLLING INTEREST

     —        —        221      —          221
                                   

Total Equity

     303,222      1,069,143      13,835      (1,082,757     303,443
                                   

TOTAL LIABILITIES AND EQUITY

   $ 1,118,729    $ 1,117,809    $ 15,394    $ (1,082,757   $ 1,169,175
                                   

 

19


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Statements of Operations

For the Three Months Ended September 30, 2009

(In thousands) (Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Subsidiary
Non-Guarantors
    Eliminations     Consolidated  

NET REVENUE:

          

Net client service revenue

   $ 7      $ 105,287      $ 7,780      $ —        $ 113,074   

Other revenue

     —          1,650        —          —          1,650   

Management fee revenue

     18,605        —          —          (18,605     —     
                                        

Total net revenue

     18,612        106,937        7,780        (18,605     114,724   
                                        

OPERATING EXPENSES:

          

Salaries and benefits

     4,169        46,605        2,282        —          53,056   

Supplies, facilities and other operating costs

     2,207        27,116        3,115        —          32,438   

Provision for doubtful accounts

     1        1,519        38        —          1,558   

Depreciation and amortization

     846        4,667        165        —          5,678   

Asset impairment

     —          2,257        —          —          2,257   

Goodwill impairment

     —          24,919        —          —          24,919   

Management fee expense

     —          17,428        1,177        (18,605     —     
                                        

Total operating expenses

     7,223        124,511        6,777        (18,605     119,906   
                                        

OPERATING INCOME (LOSS)

     11,389        (17,574     1,003        —          (5,182

INTEREST EXPENSE, NET

     (11,406     (113     —          —          (11,519
                                        

(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     (17     (17,687     1,003        —          (16,701

INCOME TAX (BENEFIT) EXPENSE

     1        1,052        (60     —          993   
                                        

(LOSS) INCOME FROM CONTINUING OPERATIONS, NET OF TAX

     (18     (18,739     1,063        —          (17,694

LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX BENEFIT OF ($429)

     —          (1,027     —          —          (1,027
                                        

NET (LOSS) INCOME

     (18     (19,766     1,063        —          (18,721

LESS: NET INCOME ATTRIBUTABLE TO THE NONCONTROLLING INTEREST

     —          —          148        —          148   

EQUITY IN INCOME OF SUBSIDIARIES, NET OF TAX

     (18,851     —          —          18,851        —     
                                        

NET INCOME (LOSS) ATTRIBUTABLE TO CRC HEALTH CORPORATION

   $ (18,869   $ (19,766   $ 915      $ 18,851      $ (18,869
                                        

 

20


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Statements of Operations

For the Three Months Ended September 30, 2008

(In thousands) (Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Subsidiary
Non-Guarantors
   Eliminations     Consolidated  

NET REVENUE:

           

Net client service revenue

   $ —        $ 112,847      $ 8,478    $ —        $ 121,325   

Other revenue

     3        2,140        3      —          2,146   

Management fee revenue

     17,133        —          —        (17,133 )     —     
                                       

Total net revenue

     17,136        114,987        8,481      (17,133 )     123,471   
                                       

OPERATING EXPENSES:

           

Salaries and benefits

     4,661        51,912        2,582      —          59,155   

Supplies, facilities and other operating costs

     1,926        29,894        3,827      —          35,647   

Provision for doubtful accounts

     1        1,644        18      —          1,663   

Depreciation and amortization

     629        4,898        163      —          5,690   

Goodwill impairment

     —          142,238        —        —          142,238   

Management fee expense

     —          15,712        1,421      (17,133 )     —     
                                       

Total operating expenses

     7,217        246,298        8,011      (17,133 )     244,393   
                                       

OPERATING INCOME (LOSS)

     9,919        (131,311 )     470      —          (120,922 )

INTEREST EXPENSE, NET

     (12,930 )     (180 )     —        —          (13,110 )

OTHER EXPENSE

     (1 )     —          —        —          (1 )
                                       

(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     (3,012 )     (131,491 )     470      —          (134,033 )

INCOME TAX (BENEFIT) EXPENSE

     (239     (10,432     67      —          (10,604 )
                                       

(LOSS) INCOME FROM CONTINUING OPERATIONS, NET OF TAX

     (2,773 )     (121,059 )     403      —          (123,429 )

LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX BENEFIT OF ($8,618)

     —          (16,204     —        —          (16,204
                                       

NET (LOSS) INCOME

     (2,773 )     (137,263 )     403      —          (139,633

LESS: NET INCOME (LOSS) ATTRIBUTABLE TO THE NONCONTROLLING INTEREST

     —          12        289      —          301   

EQUITY IN INCOME OF SUBSIDIARIES, NET OF TAX

     (137,160 )     —          —        137,160        —     
                                       

NET INCOME (LOSS) ATTRIBUTABLE TO CRC HEALTH CORPORATION

   $ (139,933 )   $ (137,275 )   $ 114    $ 137,160      $ (139,934
                                       

 

21


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Statements of Operations

For the Nine Months Ended September 30, 2009

(In thousands) (Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Subsidiary
Non-Guarantors
    Eliminations     Consolidated  

NET REVENUE:

          

Net client service revenue

   $ 20      $ 310,851      $ 14,593      $ —        $ 325,464   

Other revenue

     5        5,412        —          —          5,417   

Management fee revenue

     59,073        —          —          (59,073     —     
                                        

Total net revenue

     59,098        316,263        14,593        (59,073     330,881   
                                        

OPERATING EXPENSES:

          

Salaries and benefits

     15,199        144,161        6,090        —          165,450   

Supplies, facilities and other operating costs

     6,123        81,748        7,255        —          95,126   

Provision for doubtful accounts

     2        4,491        121        —          4,614   

Depreciation and amortization

     2,588        13,919        498        —          17,005   

Asset impairment

     —          2,257        —          —          2,257   

Goodwill impairment

     —          24,919        —          —          24,919   

Management fee expense

     —          56,529        2,544        (59,073     —     
                                        

Total operating expenses

     23,912        328,024        16,508        (59,073     309,371   
                                        

OPERATING INCOME (LOSS)

     35,186        (11,761     (1,915     —          21,510   

INTEREST EXPENSE, NET

     (34,972     (365     —          —          (35,337

OTHER EXPENSE

     (82     —          —          —          (82
                                        

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     132        (12,126     (1,915     —          (13,909

INCOME TAX EXPENSE (BENEFIT)

     (11     1,021        161        —          1,171   
                                        

INCOME (LOSS) FROM CONTINUING OPERATIONS, NET OF TAX

     143        (13,147     (2,076     —          (15,080

LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX BENEFIT OF ($1,197)

     —          (2,623     —          —          (2,623
                                        

NET INCOME (LOSS)

     143        (15,770     (2,076     —          (17,703

LESS: NET LOSS ATTRIBUTABLE TO THE NONCONTROLLING INTEREST

     —          (4     33        —          29   

EQUITY IN INCOME OF SUBSIDIARIES, NET OF TAX

     (17,875     —          —          17,875        —     
                                        

NET INCOME (LOSS) ATTRIBUTABLE TO CRC HEALTH CORPORATION

   $ (17,732   $ (15,766   $ (2,109   $ 17,875      $ (17,732
                                        

 

22


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Statements of Operations

For the Nine Months Ended September 30, 2008

(In thousands) (Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Subsidiary
Non-Guarantors
    Eliminations     Consolidated  

NET REVENUE:

          

Net client service revenue

   $ 7      $ 332,666      $ 17,235      $ —        $ 349,908   

Other revenue

     8        6,116        1        —          6,125   

Management fee revenue

     50,761        —          —          (50,761     —     
                                        

Total net revenue

     50,776        338,782        17,236        (50,761     356,033   
                                        

OPERATING EXPENSES:

          

Salaries and benefits

     12,837        156,891        7,240        —          176,968   

Supplies, facilities and other operating costs

     5,910        88,409        9,206        —          103,525   

Provision for doubtful accounts

     9        4,811        89        —          4,909   

Depreciation and amortization

     1,753        14,443        582        —          16,778   

Goodwill impairment

     —          142,238        —          —          142,238   

Management fee expense

     —          47,853        2,908        (50,761     —     
                                        

Total operating expenses

     20,509        454,645        20,025        (50,761     444,418   
                                        

OPERATING INCOME (LOSS)

     30,267        (115,863     (2,789     —          (88,385

INTEREST EXPENSE, NET

     (39,578     (554     —          —          (40,132

OTHER EXPENSE

     (34     —          —          —          (34
                                        

(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

     (9,345     (116,417     (2,789     —          (128,551

INCOME TAX BENEFIT

     (608     (7,568     (181     —          (8,357
                                        

LOSS FROM CONTINUING OPERATIONS, NET OF TAX

     (8,737     (108,849     (2,608     —          (120,194

LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX BENEFIT OF ($9,342)

     —          (17,564     —          —          (17,564
                                        

NET LOSS

     (8,737     (126,413     (2,608     —          (137,758

LESS: NET INCOME (LOSS) ATTRIBUTABLE TO THE NONCONTROLLING INTEREST

     —          21        (78     —          (57

EQUITY IN LOSS OF SUBSIDIARIES, NET OF TAX

     (128,964     —          —          128,964        —     
                                        

NET LOSS ATTRIBUTABLE TO CRC HEALTH CORPORATION

   $ (137,701   $ (126,434   $ (2,530   $ 128,964      $ (137,701
                                        

 

23


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Statements of Cash Flows

For the Nine Months Ended September 30, 2009

(In thousands) (Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Subsidiary
Non-Guarantors
    Eliminations    Consolidated  

CASH FLOWS FROM OPERATING ACTIVITIES:

           

Net cash provided by operating activities

   $ 1,839      $ 28,910      $ (1,190   $ —      $ 29,559   
                                       

CASH FLOWS FROM INVESTING ACTIVITIES:

           

Additions of property and equipment

     (1,729     (5,337     (186     —        (7,252

Proceeds from sale of property and equipment

     110        31        —          —        141   

Proceeds from sale of discontinued operations

     —          475        —          —        475   

Acquisition adjustments

     (59     —          —          —        (59

Payments made under earnout arrangement

     —          (200     —          —        (200
                                       

Net cash used in investing activities

     (1,678     (5,031     (186     —        (6,895
                                       

CASH FLOWS FROM FINANCING ACTIVITIES:

           

Intercompany transfers

     18,579        (20,470     1,891        —        —     

Capital distributed to Parent

     (221     —          —          —        (221

Capitalized financing costs

     (117     —          —          —        (117

Noncontrolling interest buyout

     (89     —          —          —        (89

Repayments of capital lease obligations

     —          (10     —          —        (10

Repayments under revolving line of credit

     (13,000     —          —          —        (13,000

Repayments of term loan and seller notes

     (5,313     —          —          —        (5,313
                                       

Net cash used in financing activities

     (161     (20,480     1,891        —        (18,750
                                       

INCREASE IN CASH AND CASH EQUIVALENTS

     —          3,399        515        —        3,914   

CASH AND CASH EQUIVALENTS Beginning of period

     —          2,180        360        —        2,540   
                                       

CASH AND CASH EQUIVALENTS End of period

   $ —        $ 5,579      $ 875      $ —      $ 6,454   
                                       

 

24


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Condensed Consolidating Statements of Cash Flows

For the Nine Months Ended September 30, 2008

(In thousands) (Unaudited)

 

     CRC Health
Corporation
    Subsidiary
Guarantors
    Subsidiary
Non-Guarantors
    Eliminations    Consolidated  

CASH FLOWS FROM OPERATING ACTIVITIES:

           

Net cash (used in) provided by operating activities

   $ (17,485   $ 39,659      $ (1,084   $ —      $ 21,090   
                                       

CASH FLOWS FROM INVESTING ACTIVITIES:

           

Additions of property and equipment-net

     (4,257     (13,893     (437     —        (18,587

Proceeds from sale of property and equipment

     —          101        —          —        101   

Acquisition of business, net of cash acquired

     (11,567     —          —          —        (11,567

Acquisition adjustments

     —          (10     —          —        (10

Payments made under earnout arrangements

     (2,947     —          —          —        (2,947
                                       

Net cash used in investing activities

     (18,771     (13,802     (437     —        (33,010
                                       

CASH FLOWS FROM FINANCING ACTIVITIES:

           

Intercompany transfers

     26,423        (28,091     1,668        —        —     

Capital distributed to Parent

     (305     —          —          —        (305

Capitalized financing costs

     (187     —          —          —        (187

Repayments of capital lease obligations

     —          (17     —          —        (17

Net borrowings under revolver line of credit

     13,500        —          —          —        13,500   

Repayments of term loan and seller notes

     (3,175     —          —          —        (3,175
                                       

Net cash provided by (used in) financing activities

     36,256        (28,108     1,668        —        9,816   
                                       

(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

     —          (2,251     147        —        (2,104

CASH AND CASH EQUIVALENTS-Beginning of period

     —          4,929        189        —        5,118   
                                       

CASH AND CASH EQUIVALENTS-End of period

   $ —        $ 2,678      $ 336      $ —      $ 3,014   
                                       

14. RESTRUCTURING

During the three and nine months ended September 30, 2009, the Company continued restructuring under the FY08 Plan. Actions under the FY08 Plan are focused on those facilities negatively impacted by the economic crisis and the depressed credit market and include facility consolidations and exits as well as certain workforce reductions. During the three months ended September 30, 2009, the Company closed one facility within its healthy living division. During the nine months ended September 30, 2009, the Company closed two programs within its healthy living division and one facility within its recovery division. For the three and nine months ended September 30, 2009, the Company continued to eliminate certain employee positions across all divisions.

 

25


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Facility exit actions include the closure, sale, or disposal of certain facilities across all divisions and are expected to be substantially completed by the end of 2009. A summary of restructuring activity, including those classified as discontinued operations is shown in the table below:

 

     Workforce
Reduction
    Consolidation and Exit of
Excess Facilities
    Total  
           (in thousands)        

Restructuring reserve as of December 31, 2008

   $ 176      $ 3,104      $ 3,280   

Expenses

     924        1,650        2,574   

Cash (payments) receipts, net

     (645     (1,062     (1,707
                        

Restructuring reserve as of September 30, 2009

   $ 455      $ 3,692      $ 4,147   
                        

Under the FY08 Plan, the Company recorded non-cash impairment charges of $0.3 million and $0.8 million for indefinite-lived intangible assets during the three months and nine months ended September 30, 2009, respectively. The Company also recognized non-cash impairment charges of $0.6 million and $1.5 million for finite-lived intangible assets, for the three months and nine months ended September 30, 2009 respectively. Additionally the Company incurred non-impairment restructuring charges of $0.1 million and $0.2 million for write-off of property and equipment during the three months and nine months ended September 30, 2009, respectively.

For the three months ended September 30, 2009, non-impairment restructuring charges totaled $0.2 million and $0.5 million for the Company’s healthy living division and its recovery division respectively. For the nine months ended September 30, 2009, the Company recognized non-impairment restructuring charges of $1.3 million each within its healthy living division and within its recovery division.

15. DISCONTINUED OPERATIONS

As part of the FY08 Plan, the Company announced its intention to sell, dispose, or cease operations at certain of its facilities across each of its business divisions. At December 31, 2008, these facilities included one therapeutic boarding school and one eating disorder start-up in its healthy living division, and eight outpatient treatment clinics in its recovery division. During the nine months ended September 30, 2009, the Company classified three additional facilities as discontinued operations which included one outdoor program and one therapeutic boarding school within its healthy living division and one outpatient facility within its recovery division. For the nine months ended September 30, 2009, the Company had classified a total of thirteen facilities as discontinued operations. During the nine months ended September 30, 2009, the Company consummated the sale of three facilities classified as held for sale.

Activities related to discontinued operations are recognized in the Company’s condensed consolidated statements of operations under discontinued operations for all periods presented.

The results of operations for those facilities classified as discontinued operations are summarized below (in thousands):

 

    Three Months
Ended

September 30,
2009
    Three Months
Ended

September 30,
2008
    Nine Months
Ended

September 30,
2009
    Nine Months
Ended

September 30,
2008
 

Net revenue

  $ 609      $ 2,954      $ 3,257      $ 8,738   

Operating expenses

    1,160        3,896        4,728        11,764   

Asset impairment

    886        23,880        2,303        23,880   

Loss on disposals

    19        —          46        —     

Loss before income taxes

    (1,456     (24,822     (3,820     (26,906

Tax benefit

    (429     (8,618     (1,197     (9,342
                               

Loss from discontinued operations

  $ (1,027   $ (16,204   $ (2,623   $ (17,564
                               

 

26


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

16. SEGMENT INFORMATION

Effective January 1, 2009, the Company realigned its operations and internal organizational structure by combining its “youth division” with its “healthy living division.” The healthy living division was previously included as a component of “corporate/other.” There were no organizational changes to the Company’s recovery division.

The Company has two identified operating segments under the new organizational structure: recovery division and healthy living division. For segment reporting purposes, the Company’s two operating segments are its two reportable segments. All periods presented have been adjusted to give effect to the change in reportable segments.

Reportable segments are based upon the Company’s internal organizational structure, the manner in which operations are managed and on the level at which the Company’s chief operating decision-maker allocates resources. The Company’s chief operating decision-maker is its Chief Executive Officer. The financial information used by the Company’s chief operating decision-maker includes net revenue, operating expenses, income (loss) from operations, total assets and capital expenditures.

The Company’s reportable segments are as follows:

Recovery-The recovery reportable segment specializes in the treatment of chemical dependency and other behavioral health disorders both on an inpatient residential basis and on an outpatient basis. Services offered in this segment include: comprehensive treatment centers (“CTC”), inpatient/residential care, partial/day treatment, intensive outpatient groups, therapeutic living/half-way house environments, aftercare centers and detoxification. As of September 30, 2009, the recovery segment provided substance abuse and behavioral health services to patients at 98 facilities located in 21 states.

Healthy Living-The healthy living segment includes programs and treatment services for adolescent youth as well as treatment services for eating disorders and weight management serving all age groups. Adolescent and youth treatment services include therapeutic and educational programs for children and adolescents struggling with academic, emotional, and behavioral issues. As of September 30, 2009, the healthy living segment operated 25 youth educational facilities in 8 states, and its offerings include adolescent therapeutic boarding schools and youth experiential outdoor education programs and summer camps. As of September 30, 2009, the healthy living segment also operated 18 facilities in 9 states, one facility in the United Kingdom, and one facility in Canada which provided eating disorder treatment services, obesity treatment services, and weight loss programs.

Major Customers-No single customer represented 10% or more of the Company’s total net revenue in any period presented.

Geographic Information-The Company’s business operations are primarily in the United States.

 

27


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

Selected segment financial information for the Company’s reportable segments was as follows (in thousands):

 

     Three Months Ended
September 30, 2009
    Three Months Ended
September 30, 2008
    Nine Months Ended
September 30, 2009
    Nine Months Ended
September 30, 2008
 

Net revenue:

        

Recovery division

   $ 78,531      $ 78,808      $ 231,980      $ 232,500   

Healthy living division

     36,133        44,607        98,715        123,294   

Corporate

     60        56        186        239   
                                

Total consolidated net revenue

   $ 114,724      $ 123,471      $ 330,881      $ 356,033   
                                

Operating expenses:

        

Recovery division

   $ 52,753      $ 54,827      $ 159,939      $ 164,701   

Healthy living division

     59,917        182,331        125,437        259,155   

Corporate

     7,236        7,235        23,995        20,562   
                                

Total consolidated operating expenses

   $ 119,906      $ 244,393      $ 309,371      $ 444,418   
                                

Operating (loss) income:

        

Recovery division

   $ 25,778      $ 23,981      $ 72,041      $ 67,799   

Healthy living division

     (23,784     (137,724     (26,722     (135,861

Corporate

     (7,176     (7,179     (23,809     (20,323
                                

Total consolidated operating (loss) income

   $ (5,182   $ (120,922   $ 21,510      $ (88,385
                                

Operating (loss) income:

        

Total consolidated operating (loss) income

   $ (5,182   $ (120,922   $ 21,510      $ (88,385

Interest expense, net

     (11,519     (13,110     (35,337     (40,132

Other expense

     —          (1     (82     (34
                                

Total consolidated (loss) income from continuing operations before income taxes

   $ (16,701   $ (134,033   $ (13,909   $ (128,551
                                

Capital expenditures:

        

Recovery division

   $ 1,515      $ 3,175      $ 3,856      $ 8,890   

Healthy living division

     593        1,656        1,667        5,438   

Corporate

     489        1,271        1,729        4,258   
                                

Total consolidated capital expenditures

   $ 2,597      $ 6,102      $ 7,252      $ 18,587   
                                
                 September 30,
2009
    December 31,
2008
 

Total assets:

        

Recovery division

       $ 896,928      $ 899,360   

Healthy living division

         187,497        222,525   

Corporate

         49,818        47,290   
                    

Total consolidated assets

       $ 1,134,243      $ 1,169,175   
                    

17. SUBSEQUENT EVENTS

The Company has evaluated events occurring from the balance sheet date of September 30, 2009 through the financial statements issuance date of November 16, 2009. During the evaluation period in October and November 2009, the Company elected to permanently close two programs within the healthy living division. In one case, a state agency temporarily suspended the program’s license after finding that the

 

28


Table of Contents

CRC HEALTH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

program was in violation of licensing requirements; the state had commenced an investigation following a complaint. The Company disagrees with these findings and intends to contest the findings. In the second case, the state is investigating the circumstances involving a student fatality. The state required that the students be removed from the program to other programs pending the outcome of the investigation. Through September 30, 2009, the combined revenue from these two programs accounted for approximately $6.0 million.

As a result of the Company’s decision to close the programs, the Company expects that it will incur restructuring costs related to work-force terminations of approximately $0.4 million. Additionally, the Company expects that during the fourth quarter of 2009, it will incur non-cash impairment charges for intangible assets of approximately $6.9 million and non-cash impairment charges of approximately $0.5 million for fixed assets. Costs related to the closure of the two programs are estimated amounts which are subject to future revision as more information becomes available.

 

29


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with the Unaudited Condensed Consolidated Financial Statements and the related notes that appear elsewhere in this Quarterly Report.

Unless the context otherwise requires, in this management’s discussion and analysis of financial condition and results of operations, the terms “our company,” “we,” “us,” “the Company” and “our” refer to CRC Health Corporation and its consolidated subsidiaries.

OVERVIEW

We are a leading provider of substance abuse treatment services and youth treatment services in the United States. We also provide treatment services for other addiction diseases and behavioral disorders such as eating disorders. Effective January 1, 2009, the Company realigned its operations and internal organizational structure by combining its “youth division” with its “healthy living division”, formerly included as a component of “corporate/other.” There were no organizational changes to the Company’s recovery division.

We deliver our services through our two divisions, the recovery division and the healthy living division. Our recovery division provides substance abuse and behavioral disorder treatment services through our residential treatment facilities and outpatient treatment clinics. Our healthy living division provides therapeutic and educational programs to underachieving young people through residential schools and wilderness programs. Our healthy living division also provides treatment services through adolescent and adult weight management programs as well as eating disorder facilities. Our healthy living division and our recovery division are also our two reportable segments.

We have two operating segments: recovery division and healthy living division. As of September 30, 2009, our recovery division, which operates 29 inpatient and 69 outpatient facilities in 21 states, provides treatment services to patients suffering from chronic addiction related diseases and related behavioral disorders. As of September 30, 2009, our healthy living division, which operates 25 youth programs in 8 states and provides a wide variety of therapeutic and educational programs for underachieving young people. The healthy living division also operates 18 weight management facilities in 9 states, one facility in the United Kingdom and one facility in Canada with a focus on providing treatment services for eating disorders and weight management. Other activities classified as corporate represent revenue and expenses associated with eGetgoing, an online internet treatment option, and general and administrative expenses (i.e., expenses associated with our corporate offices in Cupertino, California, which provides management, financial, human resource and information system support).

Basis of Presentation

CRC Health Corporation (“the Company”) is a wholly owned subsidiary of CRC Health Group, Inc., referred to as “the Group” or “the Parent.” The Company is headquartered in Cupertino, California and through its wholly owned subsidiaries provides substance abuse treatment services and youth treatment services in the United States. The Company also provides treatment services for other addiction diseases and behavioral disorders such as eating disorders.

EXECUTIVE SUMMARY

We generate revenue by providing substance abuse treatment services and youth treatment services. We also generate revenue by providing treatment services for other specialized behavioral disorders such as eating disorders. Revenue is recognized when rehabilitation and treatment services are provided to a client. Client service revenue is reported at the estimated net realizable amounts from clients, third-party payors and others for services rendered. Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for estimated third-party payor settlements are provided for in the period the related services are rendered and adjusted in future periods as final settlements are determined. Revenue for educational services provided to youth consists primarily of tuition, enrollment fees, alumni services and ancillary charges. Tuition revenue and ancillary charges are recognized based on contracted monthly/daily rates as services are rendered. The enrollment fees for service contracts that are charged upfront are deferred and recognized over the average student length of stay, approximately ten months. Alumni fee revenue represents non-refundable upfront fees for post graduation services and these fees are deferred and recognized systematically over the contracted life. During the three months ended September 30, 2009 and 2008, we generated 80.2% and 84.1% of our net revenue from non-governmental sources, including 65.1% and 69.5% from self payors, respectively, and 15.1% and 14.6% from commercial payors, respectively. During the nine months ended September 30, 2009 and 2008, we generated 80.7% and 84.0% of our net revenue from non-governmental sources, including 65.0% and 68.7% from self payors, respectively, and 15.7% and 15.2% from commercial payors, respectively. Substantially all of our government program net revenue was received from multiple counties and states under Medicaid and similar programs.

During the three and nine months ended September 30, 2009, our consolidated same-facility net revenue decreased by $9.9 million and $28.4 million, or 8.1% and 8.0%, respectively when compared to the comparable periods in 2008. On a consolidated

 

30


Table of Contents

basis, same-facility operating expenses decreased $5.2 million and $20.4 million or 6.2% and 8.1% respectively during the three and nine months ended September 30, 2009. “Same facility” means a comparison over the comparable period of the financial performance of a facility we have operated for at least one year. Our operating expenses include salaries and benefits, supplies, facilities and other operating costs, provision for doubtful accounts, depreciation and amortization, asset impairment, and goodwill impairment. Operating expenses for our recovery and healthy living divisions exclude corporate level general and administrative costs (i.e., expenses associated with our corporate offices in Cupertino, California, which provide management, financial, human resources and information systems support), stock-based compensation expense and expenses associated with eGetgoing. Healthy living division operating expenses include $2.3 million of asset impairments for the three months and nine months ended September 30, 2009 and $24.9 million and $142.2 million of goodwill impairment for the three months and nine months ended September 30, 2009 and 2008, respectively.

In October and November 2009, the Company elected to close two programs within the healthy living division. In one case, a state agency temporarily suspended the program’s license after finding that the program was in violation of licensing requirements; the state had commenced an investigation following a complaint. The Company disagrees with these findings and intends to contest the findings. In the second case, the state is investigating the circumstances involving a student fatality. The state required that the students be removed from the program to other programs pending the outcome of the investigation. Through September 30, 2009, the combined revenue from these two programs accounted for approximately $6.0 million.

As a result of the Company’s decision to close the programs, the Company expects that it will incur restructuring costs related to work-force terminations of approximately $0.4 million. Additionally, the Company expects that during the fourth quarter of 2009, it will incur non-cash impairment charges for intangible assets of approximately $6.9 million and non-cash impairment charges of approximately $0.5 million for fixed assets. Costs related to the closure of the two programs are estimated amounts which are subject to future revision as more information becomes available.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

General

The accompanying discussion and analysis of our financial condition and results of operations are based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, net revenue and expenses. We have based our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our senior management has reviewed our critical accounting policies and their application in the preparation of our financial statements and related disclosures and discussed the development, selection and disclosure of significant estimates. To the extent that actual results differ from those estimates, our future results of operations may be affected. We believe that there have not been any significant changes during the three and nine months ended September 30, 2009 to the items that we have previously reported in our critical accounting policies in management’s discussion and analysis of financial condition and results of operations for the year ended December 31, 2008 in our Annual Report on Form 10-K.

Recently Adopted Accounting Guidance

During the third quarter of 2009, the Company adopted the new Accounting Standards Codification (ASC) as issued by the Financial Accounting Standards Board (FASB). The ASC has become the source of authoritative US GAAP recognized by the FASB to be applied by nongovernmental entities. The ASC is not intended to change or alter existing GAAP. The adoption of the ASC did not have a material impact on the Company’s consolidated financial statements.

In May 2009, the FASB issued new accounting and disclosure guidance for recognized and non-recognized subsequent events that occur after the balance sheet date but before financial statements are issued. The new guidance also requires disclosure of the date through which an entity has evaluated subsequent events and the basis for that date. The new accounting guidance was effective for the Company beginning with three and six months ended June 30, 2009, and is being applied prospectively. This change in accounting policy had no impact on the consolidated financial statements.

In April 2009, the FASB issued new disclosure guidance which requires enhanced interim period disclosures about the fair value of financial instruments. The new guidance requires disclosure of the methods and significant assumptions used to estimate fair value of financial instruments on an interim basis as well as changes of the methods and significant assumptions from prior periods. The Company applied the new accounting pronouncements beginning with three and six months ended June 30, 2009, and is being applied prospectively. The adoption did not have a material impact on the consolidated financial statements.

In March 2008, the FASB amended existing disclosure requirements related to derivative and hedging activities, which became effective for the Company on January 1, 2009, and is being applied prospectively. As a result of the amended disclosure requirements,

 

31


Table of Contents

the Company is required to provide expanded qualitative and quantitative disclosures about derivatives and hedging activities in each interim and annual period. The adoption of the new disclosure requirements had no material impact on the consolidated financial statements.

In December 2007, the FASB amended its guidance on accounting for business combinations. The new accounting guidance resulted in a change in the Company’s accounting policy effective January 1, 2009, and is being applied prospectively to all business combinations subsequent to the effective date. Among other things, the new guidance amends the principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree and the goodwill acquired. It also establishes new disclosure requirements to enable the evaluation of the nature and financial effects of the business combination. The adoption of this new accounting policy did not have a significant impact on the consolidated financial statements, and the impact it will have on the consolidated financial statements in future periods will depend on the nature and size of business combinations completed subsequent to the date of adoption.

In December 2007, the FASB issued new accounting and disclosure guidance related to noncontrolling interests in subsidiaries (previously referred to as minority interests), which resulted in a change in accounting policy effective January 1, 2009. Among other things, the new guidance requires that a noncontrolling interest in a subsidiary be accounted for as a component of equity separate from the parent’s equity, rather than as a liability. The new guidance is being applied prospectively, except for the presentation and disclosure requirements, which have been applied retrospectively. The adoption of this new accounting policy did not have a significant impact on the consolidated financial statements.

Recent Accounting Guidance Not Yet Adopted

In August 2009, the FASB issued a new accounting standard which provides additional guidance on the measurement of liabilities at fair value. Specifically, when a quoted price in an active market for the identical liability is not available, the new standard requires that the fair value of a liability be measured using one or more of the valuation methods permitted by the guidance.

 

32


Table of Contents

RESULTS OF OPERATIONS

The following table presents our results of operations by segment for the three and nine months ended September 30, 2009 and 2008 (dollars in thousands, except for percentages; percentages are calculated as percentage of total net revenue unless otherwise indicated).

 

Statement of Income Data:

   Three Months Ended September 30,     Nine Months Ended September 30,  
   2009     %     2008     %     2009     %     2008     %  

Net revenue:

                

Recovery division

   $ 78,531      68.5 %   $ 78,808      63.8 %   $ 231,980      70.1 %   $ 232,500      65.3 %

Healthy living division

     36,133      31.4 %     44,607      36.1 %     98,715      29.8 %     123,294      34.6 %

Corporate

     60      0.1 %     56      0.1 %     186      0.1 %     239      0.1 %
                                                        

Total net revenue

     114,724      100.0 %     123,471      100.0 %     330,881      100.0 %     356,033      100.0 %

Operating expenses:

                

Recovery division

     52,753      46.0 %     54,827      44.4 %     159,939      48.3 %     164,701      46.3 %

Healthy living division1

     59,917      52.2 %     182,331      147.7 %     125,437      37.9 %     259,155      72.8 %

Corporate

     7,236      6.3 %     7,235      5.9 %     23,995      7.3 %     20,562      5.8 %
                                                        

Total operating expenses

     119,906      104.5 %     244,393      198.0 %     309,371      93.5 %     444,418      124.8 %

Operating income (loss):

                

Recovery division

     25,778      22.5 %     23,981      19.4 %     72,041      21.8 %     67,799      19.0 %

Healthy living division

     (23,784   (20.7 )%     (137,724   (111.5 )%      (26,722   (8.1 )%     (135,861 )   (38.2 )%

Corporate

     (7,176   (6.3 )%     (7,179   (5.8 )%     (23,809   (7.2 )%     (20,323   (5.7 )%
                                                        

Total operating income

     (5,182   (4.5 )%     (120,922 )   (97.9 )%     21,510      6.5 %     (88,385 )   (24.8 )%

Interest expense, net

     (11,519       (13,110       (35,337       (40,132  

Other expense

     —            (1       (82       (34  
                                        

Loss from continuing operations before income taxes

     (16,701 )       (134,033 )       (13,909 )       (128,551 )  

Income tax expense (benefit)

     993          (10,604 )       1,171          (8,357 )  
                                        

Loss from continuing operations, net of tax

     (17,694 )       (123,429 )       (15,080 )       (120,194 )  

Loss from discontinued operations, (net of tax benefit of ($429) and ($8,618) in the three months ended September 30, 2009 and 2008, respectively, and ($1,197) and ($9,342) in the nine months ended September 30, 2009 and 2008, respectively)

     (1,027       (16,204       (2,623       (17,564  
                                        

Net loss

     (18,721       (139,934       (17,703       (137,758 )  

Less: Net income (loss) attributable to the noncontrolling interest

     148          301          29          (57  
                                        

Net income attributable to CRC Health Corporation

   $ (18,869     $ (139,934 )     $ (17,732 )     $ (137,701 )  
                                        

 

(1) Healthy living division operating expenses include $2.3 million of asset impairments for the three months and nine months ended September 30, 2009 and $24.9 million and $142.2 million of goodwill impairment for the three months and nine months ended September 30, 2009 and 2008, respectively.

Three Months Ended September 30, 2009 Compared to Three Months Ended September 30, 2008

Consolidated net revenue decreased $8.8 million, or 7.1%, to $114.7 million for the three months ended September 30, 2009 from $123.5 million for the three months ended September 30, 2008. Of the total net revenue decrease, healthy living contributed a decrease of $8.5 million, or 19.1%, consisting of decreases of $4.8 million and $3.5 million, or 21.6% and 27.9%, in adolescent therapeutic boarding schools and in adolescent outdoor programs, respectively. Revenue decreases in the healthy living division are primarily attributable to a decline in the demand for the services offered by the division. We believe decreases in demand are a result of a weak economy and the inability of families and individuals to access the credit markets and student loan markets to fund the tuition. Recovery division revenue remained flat year over year with revenue decreases in some facilities mostly offset by revenue increases in other facilities.

 

33


Table of Contents

On a same facility basis, healthy living division net revenue decreased $9.2 million, or 20.8%. Of the $9.2 million decrease of same facility net revenue within our healthy living division, $4.8 million and $3.5 million, or 21.6% and 27.9%, was attributable to decreases in our adolescent residential boarding schools and adolescent outdoor programs respectively. The remaining decrease resulted from a decrease of $0.9 million in weight management revenues. On a same facility basis, recovery division revenue decreased $0.7 million or 1.0% primarily due to a $2.2 million revenue decrease in residential treatment centers partially offset by a $1.5 million revenue increase from comprehensive treatment centers (“CTCs”).

Consolidated operating expenses decreased $124.5 million, or 50.9%, to $119.9 million for the three months ended September 30, 2009 from $244.4 million in the same period of 2008. The $124.5 million decrease in operating expenses was primarily driven by decreases in non-cash, goodwill impairment charges of $117.3 million for the healthy living division.

After considering non-cash impairment charges, consolidated operating expenses decreased $9.4 million, or 9.3% year over year. Of the decrease in operating expenses, $2.1 million is attributable to the recovery division with $1.1 million related to decrease in salaries in and benefits and $1.0 million related to decreases in supplies, facilities, and other costs. The remaining $7.3 million is related to decrease in operating expenses within the healthy living division primarily driven by $4.6 million decrease in salaries and benefits and a decrease of $2.4 million related to supplies facilities and other. On a same facility basis, after considering non-cash impairment charges, healthy living division same facility operating expenses decreased $5.7 million or 16.1%. Of the $5.7 million decrease, $3.4 million was due to decreases in salaries and benefits with decreases of $1.6 million in adolescent residential boarding schools, $1.5 million in adolescent outdoor programs, and weight management contributing to the remaining $0.3 million decrease in same facility division salaries and benefits. The remaining $2.3 million decrease in healthy living division same facility operating expenses was primarily due to decreased expenditures within supplies, facilities and other costs of $0.7 million each in adolescent residential boarding schools and in adolescent outdoor programs, and $0.8 million in weight management. Same facility operating expenses within the recovery division decreased $1.8 million driven by expense decreases at residential facilities consisting of a $0.7 million decrease and a $1.1 million decrease in salaries and benefits and supplies, facilities, and other costs respectively.

Our consolidated operating margin was (4.5)% in the quarter ended September 30, 2009 compared to (97.9)% in the comparable period of 2008. The decrease in negative operating margin resulted from a decrease of $117.3 million in goodwill impairment year over year. On a same facility basis, our consolidated operating margin decreased to 29.9% in the quarter ended September 30, 2009 compared to 31.3% in the same quarter of 2008. On a same facility basis, healthy living division operating margin decreased to 9.4% in the quarter ended September 30, 2009 compared to 20.4% in the same period of 2008. Recovery division same facility operating margin increased to 39.1% in the quarter ended September 30, 2009 compared to 37.5% in the quarter ended September 30, 2008.

For the three months ended September 30, 2009, consolidated net loss from continuing operations decreased by approximately $105.7 million year over year resulting in a loss from continuing operations, net of tax, of $17.7 million compared to a loss from continuing operations, net of tax, of $123.4 million in the same period of 2008. The decrease in losses from continuing operations in 2009 compared to 2008 is primarily driven by decreases in non-cash impairment charges related to goodwill of $117.3 million.

Nine Months Ended September 30, 2009 Compared to Nine Months Ended September 30, 2008

Consolidated net revenue decreased $25.1 million, or 7.1%, to $330.9 million for the nine months ended September 30, 2009 from $356.0 million for the nine months ended September 30, 2008. Recovery division revenue remained flat year over year. Of the total net revenue decrease, the healthy living division contributed a decrease of $24.6 million, or 19.9%. The $24.6 million decrease consisted of revenue decreases of $10.3 million, or 30.9%, in adolescent outdoor programs and a decrease of $12.1 million, or 17.9%, in adolescent therapeutic boarding schools. The remaining $2.2 million decrease resulted from revenue decreases in weight management. Revenue decreases in the healthy living division are primarily attributable to lower revenue performance across the division due to a decline in demand as a result of the weak economy and the inability of families and individuals to access the credit markets and student loan markets to fund the tuition. The recovery division contributed a revenue decrease of $0.5 million, representing flat revenue growth year over year with revenue decreases in some facilities offset by revenue increases in other facilities.

On a same facility basis, our healthy living division net revenue decreased $25.4 million, or 20.7%. Of the $25.4 million decrease of same facility net revenue within our healthy living division, $12.1 million and $10.3 million, or 17.9% and 30.9% was attributable to our adolescent residential boarding schools and our adolescent outdoor programs, respectively. The remaining $3.0 million or 13.7% decrease in healthy living division revenue were due to revenue decreases of $3.0 million in weight management. Recovery division same facility revenue decreased $3.0 million or 1.3% primarily due to a $8.3 million or 5.5%, revenue decrease in residential treatment centers partially offset by a $5.3 million, or 6.6%, revenue increase in CTCs.

Consolidated operating expenses decreased $135.0 million, or 30.4%, to $309.4 million for the nine months ended September 30, 2009 from $444.4 million in the same period of 2008. The $135.0 million decrease in operating expenses was primarily driven by a decrease in non-cash, goodwill impairment charges of $117.3 million for the healthy living division.

 

34


Table of Contents

Recovery division operating expenses decreased $4.8 million year over year or 2.9% primarily due to a $2.0 million decrease in salaries and benefits and a $2.5 million decrease in supplies, facilities, and other costs. After considering the above mentioned, non-cash impairment charges, the healthy living division operating expenses decreased of $18.7 million, or 16.0% primarily due to a $11.8 million decrease in salaries and benefits as well as by a decrease of $6.0 million decrease in supplies, facilities, and other operating costs. Corporate division operating expenses increased $3.4 million or 16.7% year over year due in part to restructuring activities inclusive of the consolidation of our administrative functions. On a same facility basis, healthy living division operating expenses decreased $15.9 million or 15.5%. Of the $15.9 million decrease, $10.1 million was due to decreases in salaries and benefits with decreases of $4.4 million in adolescent residential boarding schools, $4.5 million in adolescent outdoor programs, and weight management contributing to the remaining $1.2 million decrease in same facility division salaries and benefits. The remaining $5.8 million decrease in healthy living division same facility operating expenses was due to decreased expenditures within supplies, facilities and other costs of $2.4 million in adolescent residential boarding schools, $1.6 million in adolescent outdoor programs, and $1.8 million in weight management. For our recovery division, same facility operating expenses decreased $6.7 million or 4.5% driven by decreases of $3.4 million in salaries and benefits with residential treatment centers and CTC contributing decreases of $2.7 million and $0.7 million respectively. The remaining $3.3 million decrease was primarily due to decreases in supplies, facilities, and other costs primarily within residential treatment centers.

Our consolidated operating margin was 6.5% in the nine months ended September 30, 2009 compared to (24.8)% in the comparable period of 2008. The decrease in negative operating margin resulted from a decrease of $117.3 million in goodwill impairment year over year. On a same facility basis, our consolidated operating margin increased to 29.5% compared to 29.4% in 2008. Healthy living division same facility operating margin decreased to 8.8% in 2009 compared to 16.5% in 2008. The significant decrease in our healthy living division operating margin is primarily due to lower patient census resulting from the current weak economic environment. Recovery division same facility operating margin increased to 38.3% compared to 36.2% in 2008.

For the nine months ended September 30, 2009, consolidated net loss from continuing operations, net of tax, decreased by approximately $105.1 million year over year resulting in a loss from continuing operations of $15.1 million compared to a loss from continuing operations, net of tax, of $120.2 million in the same period of 2008. The decrease in losses from continuing operations in 2009 compared to 2008 is primarily driven by decreases in non-cash impairment charges related to goodwill of $117.3 million.

Working Capital

Working capital is defined as total current assets, including cash and cash equivalents, less total current liabilities, including the current portion of long-term debt.

We had negative working capital of $8.1 million at September 30, 2009, compared to negative working capital of $14.5 million at December 31, 2008. The decrease in negative working capital from September 30, 2009 compared to December 31, 2008 is primarily attributed to an increase in cash of $3.9 million and an increase of $1.7 million in accounts receivables.

Sources and Uses of Cash

 

     Nine Months Ended
September 30,
 
   2009     2008  
   (In thousands)  

Net cash provided by operating activities

   $ 29,559      $ 21,090   

Net cash used in investing activities

     (6,895 )     (33,010 )

Net cash (used in) provided by financing activities

     (18,750 )     9,816   
                

Net increase (decrease) in cash

   $ 3,914      $ (2,104 )
                

Cash provided by operating activities was $29.6 million for the nine months ended September 30, 2009 compared to cash provided by operating activities of $21.1 million during the same period in 2008.

Cash used in investing activities was $6.9 million for the nine months ended September 30, 2009 compared to $33.0 million in the same period of 2008. The decrease in cash used in investing activities primarily relates to a decrease in the additions of property and equipment and related to two acquisitions during the comparable period of the prior year.

Cash used in financing activities was $18.8 million for the nine months ended September 30, 2009 compared to cash provided by financing activities of $9.8 million for the same period in 2008. The increase in cash used in financing activities is primarily due to a net increase in repayments of the revolving line of credit.

 

35


Table of Contents

Financing and Liquidity

We fund our ongoing operations through cash generated by operations, funds available under the revolving portion of our senior secured credit facility and existing cash and cash equivalents. As of September 30, 2009, our senior secured credit facility was comprised of a $406.7 million senior secured term loan facility and a $100.0 million revolving credit facility. At September 30, 2009, the revolving credit facility had $42.6 million available for borrowing, $48.5 million outstanding and classified on our balance sheet as long term debt, and $8.9 million of letters of credit issued and outstanding. As part of the acquisition of the Company by investment funds managed by Bain Capital Partners, LLC, we issued $200.0 million in aggregate principal amount of 10.75% senior subordinated notes due 2016 of which $177.3 million remained outstanding at September 30, 2009. We anticipate that cash generated by operations, the remaining funds available under the revolving portion of our senior secured credit facility and existing cash and cash equivalents will be sufficient to meet working capital requirements, service our debt and finance capital expenditures over the next 12 months.

We may expand existing recovery and healthy living facilities and build or acquire new facilities. Management continually assesses our capital needs and may seek additional financing, including debt or equity, to fund potential acquisitions or for other corporate purposes. We have historically made and currently intend to make payments to reduce borrowing under the revolving line of credit from operating cash flow. In addition, if future financings are executed, we expect that such financings will serve not only to partially fund acquisitions but also to repay all or part of any outstanding revolving line of credit balances then outstanding. In negotiating such financing, there can be no assurance that we will be able to raise additional capital on terms satisfactory to us. Failure to obtain additional financing on reasonable terms could have a negative effect on our plans to acquire additional treatment facilities.

Under the terms of our borrowing arrangements, we are required to comply with various covenants, including the maintenance of certain financial ratios. As of September 30, 2009, we were in compliance with all such covenants. A breach of these could result in a default under our credit facilities and in our being unable to borrow additional amounts under our revolving credit facility. If an event of default occurs, the lenders could elect to declare all amounts borrowed under our credit facilities to be immediately due and payable and the lenders under our term loans and revolving credit facility could proceed against the collateral securing the indebtedness.

 

36


Table of Contents
Item 3. Quantitative and Qualitative Disclosure about Market Risk

For quantitative and qualitative disclosures about market risk affecting us, see “Quantitative and Qualitative Disclosure about Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the year ended December 31, 2008. As of September 30, 2009, our exposure to market risk has not changed materially since December 31, 2008.

 

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We conducted an evaluation under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Quarterly Report. Based upon this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective to ensure that material information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the period covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II. OTHER INFORMATION

 

Item 1A. Risk Factors

As of September 30, 2009, there have been no material changes to the factors disclosed in Item 1A Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2008.

 

Item 6. Exhibits

The Exhibit Index beginning on page 37 of this report sets forth a list of exhibits.

 

37


Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 16, 2009

 

CRC HEALTH CORPORATION
(Registrant)

By

 

/S/    KEVIN HOGGE

  Kevin Hogge,
  Chief Financial Officer
 

(Principal Financial Officer and Principal

Accounting Officer and duly authorized signatory)

 

38


Table of Contents

CRC HEALTH CORPORATION

EXHIBIT INDEX

 

31.1

  Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer ‡

31.2

  Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer and Principal Accounting Officer ‡

32.1

  Section 1350 Certification of Principal Executive Officer †

32.2

  Section 1350 Certification of Principal Financial Officer and Principal Accounting Officer †

 

Filed herewith.
Furnished herewith.

 

39